期刊
CANCER LETTERS
卷 319, 期 1, 页码 49-55出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2011.12.031
关键词
Circulating tumor cells; Breast cancer; CellSearch; Cytokeratin; CD49f
类别
资金
- Netherlands Genomic Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)
Circulating tumor cells (CTCs) can be enumerated using CellSearch, but not all breast cancer subtypes, specifically those with epithelial-mesenchymal transition (EMT) characteristics, sufficiently express the enrichment (EpCAM) and selection (CK8/18/19) markers used in this method. While CD146 can detect EpCAM-negative CTCs, we here evaluated the value of various cytokeratins and CD49f to detect CK8/18/19-negative CTCs. The tested cytokeratins provided no substantial benefit, but adding CD49f to CK8/18/19 as a selection marker resulted in improved recovery of normal-like cell lines. Combined staining of CK8/18/19 and CD49f after CD146/EpCAM enrichment is likely to further improve CTC detection in breast cancer. (c) 2011 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据